Report cover image

Anti Fungal Drugs Market, By Drug Type (Echinocandins, Polyenes, Allylamines, Azoles, Others), By Indication (Aspergillosis, Dermatophytosis, Candidiasis, Mucormycosis, Others), By Dosage Form (Powders, Ointments, Injections, Tablets, Others), By Distribu

Publisher Coherent Market Insights
Published Mar 10, 2025
Length 164 Pages
SKU # CMI20004455

Description

Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

Market Dynamics

Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea’s antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.

Key features of the study:
  • This report provides an in-depth analysis of global antifungal drugs market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global antifungal drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market
Detailed Segmentation:
  • Global Antifungal Drugs Market, By Drug Type:
  • Echinocandins
  • Polyenes
  • Allylamines
  • Azoles
  • Others
  • Global Antifungal Drugs Market, By Indication:
  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Mucormycosis
  • Others
  • Global Antifungal Drugs Market, By Dosage Form:
  • Powders
  • Ointments
  • Drugs
  • Others
  • Global Antifungal Drugs Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • GlaxoSmithKline Plc
  • Bayer AG
  • Abbott Laboratories
  • Merck & Co., Inc
  • Glenmark Pharmaceuticals Limited
  • Enzon Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Gilead Sciences, Inc.
  • Sanofi S.A.
  • Astellas Pharma, Inc.

Table of Contents

164 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Indication
Market Snippet, By Dosage Form
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Anti Fungal Drugs Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Anti Fungal Drugs Market, By Drug Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Echinocandins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Polyenes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Allylamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Azoles
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
6. Global Anti Fungal Drugs Market, By Indication, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Aspergillosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Dermatophytosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Candidiasis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Mucormycosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
7. Global Anti Fungal Drugs Market, By Dosage Form, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Powders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ointments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Injections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
8. Global Anti Fungal Drugs Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
9. Global Anti Fungal Drugs Market, By Region, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bayer AG
Abbott Laboratories
Merck & Co., Inc
Glenmark Pharmaceuticals Limited
Enzon Pharmaceuticals, Inc
Pfizer Inc
Gilead Sciences, Inc
Sanofi S.A.
Astellas Pharma, Inc
Alembic Pharmaceuticals Limited
SCYNEXIS, Inc
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 36 market data tables and 26 figures on “Global Anti Fungal Drugs Market” - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us